White House: Unacceptable for states to target access to federally approved abortion pills
Reuters
Published Mar 03, 2023 02:08PM ET
Updated Mar 03, 2023 03:21PM ET
WASHINGTON (Reuters) - The White House said on Friday that it was "dangerous and unacceptable" for elected officials to target women's access to federally approved medication abortion pills.
Walgreens announced on Thursday it would not dispense abortion pills in the 20 states where attorneys general have told the pharmacy chain it risked breaking the law should it provide them through the mail.
"Elected officials targeting pharmacies and their ability to provide women with access to safe, effective and FDA-approved medication is dangerous and just unacceptable," Karine Jean-Pierre, press secretary for the White House, said when asked about the pharmacy's announcement.
Get The News You Want
Written By: Reuters
Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.